by Jordana Choucair | Apr 11, 2022 | Opioid/Substance Use Disorders
The Centers for Disease Control and Prevention (CDC) is expected to release updated guidelines regarding opioid prescribing practices. The proposed guidelines include some notable changes: they no longer include specific limits on the dose and duration of an opioid...
by Jordana Choucair | Mar 31, 2022 | Opioid/Substance Use Disorders
Just ahead of a trial, the state of Florida reached a settlement with three major companies over their roles in the opioid crisis. Under the agreement, CVS Health Corp. will pay $484 million, Allergan PLC will pay $134 million, and Teva Pharmaceuticals Industries Ltd....
by Jordana Choucair | Mar 22, 2022 | Opioid/Substance Use Disorders
Allergan and Teva Pharmaceutical reached a $107 million settlement with the state of Rhode Island over their alleged roles in fomenting the U.S. opioid crisis. Under the deal, Teva will pay $21.5 million over 13 years and supply the state with two medicines to combat...
by Jordana Choucair | Mar 22, 2022 | Opioid/Substance Use Disorders
A new RAND Corp. study found that less than a third of patients who were given drugs in emergency departments to treat opioid addiction follow up and continue their treatments. The study examined 92 percent of prescriptions filled at U.S. retail pharmacies before and...
by Jordana Choucair | Mar 22, 2022 | Opioid/Substance Use Disorders
According to a new study published in JAMA, alcohol-related deaths reached record levels during the first year of the COVID-19 pandemic. The number of deaths involving alcohol increased from 78, 927 in 2019 to 99,017 in 2020. Young adults ages 25 to 44 experienced the...
by Jordana Choucair | Mar 15, 2022 | Opioid/Substance Use Disorders
The House Oversight and Reform Committee asked the Justice and Treasury departments to review tax deductions claimed by four drug companies that agreed to a $26 billion settlement to end lawsuits tied to the opioid crisis. Lawmakers said the companies may be trying to...
Recent Comments